New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2013
11:56 EDTQGENQIAGEN moves up after strong earnings and guidance, levels to watch
The shares are up over 6.5% after the company turned in an earnings beat and raised guidance. At the current price of $21.28, next resistance is at $21.90. A big area of resistance stretching back several year is at $23.83. That will be an important test if and when shares get closer to that objective. Looking back on a ten year monthly chart will make that evident. Support is currently at $20.27.
News For QGEN From The Last 14 Days
Check below for free stories on QGEN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2014
16:02 EDTQGENQIAGEN acquires exclusive worldwide license to biomarker calreticulin
Subscribe for More Information
April 2, 2014
09:01 EDTQGENLeerink's life science tools analyst holds an analyst/industry conference call
Life Science Tools Analyst Leonard discusses the use of nextgen sequencing in a clinical context, early applications and uptake, the merits, demerits of various nextgen sequencing instruments and where new offerings fit on an Analyst/Industry conference call. Relevant companies ILMN, TMO, PACB, FLDM, MYGN, NSTG, GNMK, CPHD, LMNX and QGEN may be discussed on the Analyst/Industry conference call to be held on April 3 at 2 pm.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use